Patent Application
20220010349
The disclosure provides methods for producing protein-based bioplastics or protein-based biofilms using microbial biomass.
Petroleum-derived plastics have become essential to modern life, largely due to their lightness, robustness, durability, and resistance to degradation. However, dependence on petroleum-derived plastics has resulted in a score of serious problems, including crude oil depletion, pollution, and landfill accumulation. To decrease the environmental impacts of plastics, efforts are underway to replace conventional petroleum-derived plastics with bioplastics such as polylactide, polysaccharides, aliphatic polyesters and polyhydroxyalkanoates that possess similar physicochemical properties as conventional plastics (Anjum, Int J Biol Macromol, 89: 161-174, 2016).
Likewise, there is an immediate need to drastically reduce the emissions associated with global fossil fuel consumption in order to limit climate change. However, carbon-based materials, chemicals, and transportation fuels are predominantly made from fossil sources and currently there is no alternative source available to adequately displace them.
Gas fermenting microorganisms that fix carbon dioxide (CO2) and carbon monoxide (CO) can ease the effect of this dependence as they can convert gaseous carbon into useful products. Gas fermenting microorganisms can utilize a wide range of feedstocks including gasified organic matter of any sort (i.e. municipal solid waste, industrial waste, biomass, and agricultural waste residues) or industrial off-gases (i.e. from steel mills or other processing plants). Furthermore, these microorganisms have high growth rates, can be genetically modified to tailor amino acid composition, and have high protein content.
Protein-based bioplastics offer advantages in being renewable, biodegradable, and functionizable. However, methods for producing protein-based bioplastics are still largely undeveloped. There remains a need to develop methods for producing protein-based bioplastics using microorganisms as a protein source.
It is against the above background that the present disclosure provides certain advantages and advancements over the prior art.
Although this disclosure disclosed herein is not limited to specific advantages or functionalities, the disclosure provides methods of producing protein-based bioplastics or biofilms using microbial biomass.
In some aspects of the method disclosed herein, the microbial biomass comprises a microorganism grown on a gaseous substrate, such as a gaseous substrate comprising one or more of CO, CO2, and H2. The gaseous substrate may be or may be derived from an industrial waste gas, an industrial off gas, or syngas.
In some aspects of the method disclosed herein, the microorganism may be Gram-positive, acetogenic, carboxydotrophic, and/or anaerobic. Generally, the microorganism is a member of the genus Clostridium, such as a microorganism that is or is derived from Clostridium autoethanogenum, Clostridium ljungdahlii, Clostridium ragsdalei, or Clostridium coskatii.
In some embodiments of the method disclosed herein, the method includes a step of processing the microbial biomass. The processing step may comprise one or more of sterilizing the microbial biomass, centrifuging the microbial biomass, and drying the microbial biomass. The processing step may further comprise denaturation of the microbial biomass. The processing step may also comprise extraction of the microbial biomass, such as for DNA removal.
In some embodiments of the method disclosed herein, the method comprises blending the microbial biomass with a plasticizer. The plasticizer may be one or more of water, glycerol, ethylene glycerol, propylene glycerol, palmitic acid, diethyl tartarate, dibutyl tartarate, 1,2-butanediol, 1,3-butanediol, polyethylene glycol (PEG), sorbitol, mantitoletc, dimethylaniline, diphenylamine, and 2,3-butanediol.
In some embodiments of the method disclosed herein, the method comprises adding an additive to the microbial biomass. The additive may be a cross-linking agent, a reducing agent, a strengthener, a conductivity agent, a compatabilizing agent, or a water resistance agent.
The inventors have discovered that microbial biomass produced from the fermentation of gaseous substrates, particularly gaseous substrates comprising one or more of CO, CO2, and H2, is a suitable source for production of protein-based bioplastics and protein-based biofilms.
A “microorganism” or “microbe” is a microscopic organism, especially a bacterium, archea, virus, or fungus. The microorganism is typically a bacterium. As used herein, recitation of “microorganism” should be taken to encompass “bacterium.”
“Microbial biomass” refers biological material comprising microorganism cells. For example, microbial biomass may comprise or consist of a pure or substantially pure culture of a bacterium, archea, virus, or fungus. When initially separated from a fermentation broth, microbial biomass generally contains a large amount of water. This water may be removed or reduced by drying or processing the microbial biomass.
The microbial biomass may comprise any of the components listed in the first column of the table in Example 1. Notably, the microbial biomass of Example 1 comprises 15% moisture (water) by weight. Accordingly, the values listed in Example 1 refer to amounts of each component per amount of wet (i.e., non-dried) microbial biomass. Herein, the composition of the microbial biomass is described in terms of weight of a component per weight of wet (i.e., non-dried) microbial biomass. Of course, it is also possible to calculate the composition of the microbial biomass in terms of weight of a component per weight of dry microbial biomass.
The microbial biomass generally contains a large fraction of protein, such as more than 50% (50 g protein/100 g biomass), more than 60% (60 g protein/100 g biomass), more than 70% (70 g protein/100 g biomass), or more than 80% (80 g protein/100 g biomass) protein by weight. In a preferred embodiment, the microbial biomass comprises at least 72% (72 g protein/100 g biomass) protein by weight. The protein fraction comprises amino acids, including aspartic acid, alanine, arginine, cysteine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tyrosine, and/or valine.
The microbial biomass may contain a number of vitamins, including vitamins A (retinol), C, B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), and/or B6 (pyridoxine).
The microbial biomass may contain relatively small amounts of carbohydrates and fats. For example, the microbial biomass may comprise less than 15% (15 g carbohydrate/100 g biomass), less than 10% (10 g carbohydrate/100 g biomass), or less than 5% (5 g carbohydrate/100 g biomass) of carbohydrate by weight. For example, the microbial biomass may comprise less than 10% (10 g fat/100 g biomass), or less than 5% (5 g fat/100 g biomass), less than 2% (2 g fat/100 g biomass), or less than 1% (1 g fat/100 g biomass) of fat by weight.
The method of the disclosure may comprise processing or treatment steps of microbial biomass prior to utilizing the microbial biomass to produce a protein-based bioplastic or protein-based biofilm. For example, the method may comprise sterilizing the microbial biomass, centrifuging the microbial biomass, and/or drying the microbial biomass. In certain embodiments, the microbial biomass is dried using spray drying or paddle drying. The method may also comprise reducing the nucleic acid content and/or inorganic content of the microbial biomass using any method known in the art. For example, processing of the microbial biomass may comprise the use of a solvent wash.
As used herein, the terms “protein-based bioplastic,” “protein bio-based plastic” and “protein biocomposite” can be used interchangeably. “Protein-based bioplastics” and “protein-based protein-based biofilms” refer to naturally-derived biodegradable polymers. Protein-based bioplastics and protein-based biofilms are largely composed of proteins. A “protein-based material” refers to a three-dimensional macromolecular network comprising hydrogen bonds, hydrophobic interactions, and disulphide bonds. See, e.g., Martinez, Journal of Food Engineering, 17: 247-254, 2013 and Pommet, Polymer, 44: 115-122, 2003. In preferred embodiments, the protein component of a protein-based bioplastic or protein-based biofilm is microbial biomass. Production of protein-based bioplastics and protein-based biofilms may require a step of protein denaturation by chemical, thermal, or pressure-induced methods. See, e.g., Mekonnen, Biocomposites: Design and Mechanical Performance, 2015. Production of protein-based bioplastics and protein-based biofilms may further require a step of isolating or fractionating the microbial biomass to produce a purified protein material.
The protein-based bioplastic or protein-based biofilm may be a blend of a protein, such as microbial biomass, with a plasticizer. As used herein, a “plasticizer” refers to a molecule having a low molecular weight and volatility. The plasticizer is used to modify the structure of a protein by reducing the intermolecular forces present in the protein and increasing polymeric chain mobility. See, e.g., Martinez, Journal of Food Engineering, 17: 247-254, 2013 and Gennadios, CRC Press, New York, 66-115, 2002. Non-limiting examples of plasticizers include water, glycerol, ethylene glycerol, propylene glycerol, palmitic acid, diethyl tartarate, dibutyl tartarate, 1,2-butanediol, 1,3-butanediol, polyethylene glycol (PEG), sorbitol, mantitoletc, dimethylaniline, diphenylamine, and 2,3-butanediol. See, e.g., Mekonnen, Biocomposites: Design and Mechanical Performance, 2015. In some embodiments, glycerol is used as a plasticizer. In some embodiments, 30% glycerol is used as a plasticizer. In some embodiments, 2,3-butanediol, which is a native product of Clostridium autoethanogenum, is used as a plasticizer.
In some embodiments, a plasticizer is introduced into a protein matrix by physicochemical methods, such as by a “casting” method. In this method, a chemical reactant is introduced to disrupt the disulphide bonds. See, e.g., Martinez, Journal of Food Engineering, 17: 247-254, 2013 and Gontard, J. Food Sci., 57: 190-196, 1993.
In some embodiments, a plasticizer is introduced into a protein matrix by thermoplastic processing. In this method, a protein and a plasticizer are mixed by a combination of heat and shear. This method may further require thermo-mechanical treatments, such as compression molding, thermomoulding, and extrusion. See, e.g., Martinez, Journal of Food Engineering, 17: 247-254, 2013 and Felix, Industrial Crops and Products, 79: 152-159, 2016.
In some embodiments, protein/plasticizer blends are prepared by a thermo-mechanical procedure, such as by mixing to obtain a dough-like material of appropriate consistency and homogeneity. The dough-like material is then processed by injection molding to produce a protein-based bioplastic or protein-based biofilm. See, e.g., Felix, Industrial Crops and Products, 79: 152-159, 2016.
In some embodiments, an additive is required to produce a protein-based bioplastic or a protein-based biofilm. For example, the additive may be a reducing agent, a cross-linking agent, a strengthener, a conductivity agent, a compatabilizing agent, or a water resistance agent. A non-limiting example of a reducing agent is sodium bisulfite. Non-limiting examples of cross-linking agents include glyoxal, L-cysteine, and formaldehyde. Non-limiting examples of strengtheners include bacterial cellulose nanofibers, pineapple leaf fibers, lignin, flax, jute, hemp, and sisal. A non-limiting example of a conductivity agent is a carbon nanotube material. Non-limiting examples of compatabilizing agents include malic anhydride and toluene diisocyanate. A non-limiting example of a water resistance agent is a polyphosphate material. In some embodiments, chemical modifications are used to improve water resistance. The chemical modification may be esterification with low molecular weight alcohols. See, e.g., Felix, Industrial Crops and Products, 79: 152-159, 2016 and Mekonnen, Biocomposites: Design and Mechanical Performance, 2015.
In some embodiments, a protein-based bioplastic or protein-based biofilm is produced by extrusion, wherein the microbial biomass is heated and pushed through an extrusion die.
In some embodiments, a protein-based bioplastic may be blended with fossil-derived plastics, but this is not a required step.
The protein-based bioplastics described herein may be used in packaging, bags, bottles, containers, disposable dishes, cutlery, plant pots, ground cover, baling hay, buttons, or buckles.
An advantage of the present disclosure is the solubility of microbial biomass in water. Although some research has been conducted related to use of plant proteins in protein-based bioplastics, few plant proteins are soluble in common solvents, and use of solvents or alkaline solutions increases cost and may be environmentally unfriendly. Perez, Food and Bioproducts Processing, 97: 100-108, 2016.
The microorganism may classified based on functional characteristics. For example, the microorganism may be or may be derived from a C1-fixing microorganism, an anaerobe, an acetogen, an ethanologen, and/or a carboxydotroph. Table 1 provides a representative list of microorganisms and identifies their functional characteristics.
Acetobacterium woodii
Clostridium aceticum
Clostridium autoethanogenum
Clostridium carboxidivorans
Clostridium coskatii
Clostridium drakei
Clostridium formicoaceticum
Clostridium ljungdahlii
Clostridium magnum
Clostridium ragsdalei
Clostridium scatologenes
Eubacterium limosum
Moorella thermautotrophica
Moorella thermoacetica (formerly
−4
Clostridium thermoaceticum)
Oxobacter pfennigii
Sporomusa ovata
Sporomusa silvacetica
Sporomusa sphaeroides
Thermoanaerobacter kiuvi
1
Acetobacterium woodi can produce ethanol from fructose, but not from gas.
2It has been reported that Acetobacterium woodi can grow on CO, but the methodology is questionable.
3It has not been investigated whether Clostridium magnum can grow on CO.
4One strain of Moorella thermoacetica, Moorella sp. HUC22−1, has been reported to produce ethanol from gas.
5It has not been investigated whether Sporomusa ovata can grow on CO.
6It has not been investigated whether Sporomusa silvacetica can grow on CO.
7It has not been investigated whether Sporomusa sphaeroides can grow on CO.
“C1” refers to a one-carbon molecule, for example, CO or CO2. “C1-oxygenate” refers to a one-carbon molecule that also comprises at least one oxygen atom, for example, CO or CO2. “C1-carbon source” refers a one carbon-molecule that serves as a partial or sole carbon source for the microorganism. For example, a C1-carbon source may comprise one or more of CO, CO2, or CH2O2. Preferably, the C1-carbon source comprises one or both of CO and CO2. A “C1-fixing microorganism” is a microorganism that has the ability to produce one or more products from a C1-carbon source. Typically, the microorganism is a C1-fixing bacterium. In a preferred embodiment, the microorganism is or is derived from a C1-fixing microorganism identified in Table 1.
An “anaerobe” is a microorganism that does not require oxygen for growth. An anaerobe may react negatively or even die if oxygen is present above a certain threshold. Typically, the microorganism is an anaerobe (i.e., is anaerobic). In a preferred embodiment, the microorganism is or is derived from an anaerobe identified in Table 1.
An “acetogen” is a microorganism that produces or is capable of producing acetate (or acetic acid) as a product of anaerobic respiration. Typically, acetogens are obligately anaerobic bacteria that use the Wood-Ljungdahl pathway as their main mechanism for energy conservation and for synthesis of acetyl-CoA and acetyl-CoA-derived products, such as acetate (Ragsdale, Biochim Biophys Acta, 1784: 1873-1898, 2008). Acetogens use the acetyl-CoA pathway as a (1) mechanism for the reductive synthesis of acetyl-CoA from CO2, (2) terminal electron-accepting, energy conserving process, (3) mechanism for the fixation (assimilation) of CO2 in the synthesis of cell carbon (Drake, Acetogenic Prokaryotes, In: The Prokaryotes, 3rd edition, p. 354, New York, N.Y., 2006). All naturally occurring acetogens are C1-fixing, anaerobic, autotrophic, and non-methanotrophic. In a preferred embodiment, the microorganism is an acetogen. In a preferred embodiment, the microorganism is or is derived from an acetogen identified in Table 1.
An “ethanologen” is a microorganism that produces or is capable of producing ethanol. In a preferred embodiment, the microorganism is an ethanologen. In a preferred embodiment, the microorganism is or is derived from an ethanologen identified in Table 1.
An “autotroph” is a microorganism capable of growing in the absence of organic carbon. Instead, autotrophs use inorganic carbon sources, such as CO and/or CO2. In a preferred embodiment, the microorganism is an autotroph. In a preferred embodiment, the microorganism is or is derived from an autotroph identified in Table 1.
A “carboxydotroph” is a microorganism capable of utilizing CO as a sole source of carbon. In a preferred embodiment, the microorganism is a carboxydotroph. In a preferred embodiment, the microorganism is or is derived from a carboxydotroph identified in Table 1.
In certain embodiments, the microorganism does not consume certain substrates, such as methane or methanol. In one embodiment, the microorganism is not a methanotroph and/or is not a methylotroph.
Preferably, the microorganism is Gram-positive. More broadly, the microorganism may be or may be derived from any genus or species identified in Table 1. For example, the microorganism may be a member of the genus Clostridium.
In a preferred embodiment, the microorganism is or is derived from the cluster of Clostridia comprising the species Clostridium autoethanogenum, Clostridium ljungdahlii, and Clostridium ragsdalei. These species were first reported and characterized by Abrini, Arch Microbiol, 161: 345-351, 1994 (Clostridium autoethanogenum), Tanner, Int J System Bacteriol, 43: 232-236, 1993 (Clostridium ljungdahlii), and Huhnke, WO 2008/028055 (Clostridium ragsdalei).
These three species have many similarities. In particular, these species are all C1-fixing, anaerobic, acetogenic, ethanologenic, and carboxydotrophic members of the genus Clostridium. These species have similar genotypes and phenotypes and modes of energy conservation and fermentative metabolism. Moreover, these species are clustered in clostridial rRNA homology group I with 16S rRNA DNA that is more than 99% identical, have a DNA G+C content of about 22-30 mol %, are gram-positive, have similar morphology and size (logarithmic growing cells between 0.5-0.7×3-5 μm), are mesophilic (grow optimally at 30-37° C.), have similar pH ranges of about 4-7.5 (with an optimal pH of about 5.5-6), lack cytochromes, and conserve energy via an Rnf complex. Also, reduction of carboxylic acids into their corresponding alcohols has been shown in these species (Perez, Biotechnol Bioeng, 110:1066-1077, 2012). Importantly, these species also all show strong autotrophic growth on CO-containing gases, produce ethanol and acetate (or acetic acid) as main fermentation products, and produce small amounts of 2,3-butanediol and lactic acid under certain conditions.
However, these three species also have a number of differences. These species were isolated from different sources: Clostridium autoethanogenum from rabbit gut, Clostridium ljungdahlii from chicken yard waste, and Clostridium ragsdalei from freshwater sediment. These species differ in utilization of various sugars (e.g., rhamnose, arabinose), acids (e.g., gluconate, citrate), amino acids (e.g., arginine, histidine), and other substrates (e.g., betaine, butanol). Moreover, these species differ in auxotrophy to certain vitamins (e.g., thiamine, biotin). These species have differences in nucleic and amino acid sequences of Wood-Ljungdahl pathway genes and proteins, although the general organization and number of these genes and proteins has been found to be the same in all species (Kopke, Curr Opin Biotechnol, 22: 320-325, 2011).
Thus, in summary, many of the characteristics of Clostridium autoethanogenum, Clostridium ljungdahlii, or Clostridium ragsdalei are not specific to that species, but are rather general characteristics for this cluster of C1-fixing, anaerobic, acetogenic, ethanologenic, and carboxydotrophic members of the genus Clostridium. However, since these species are, in fact, distinct, the genetic modification or manipulation of one of these species may not have an identical effect in another of these species. For instance, differences in growth, performance, or product production may be observed.
The microorganism may also be or be derived from an isolate or mutant of Clostridium autoethanogenum, Clostridium ljungdahlii, or Clostridium ragsdalei. Isolates and mutants of Clostridium autoethanogenum include JA1-1 (DSM10061) (Abrini, Arch Microbiol, 161: 345-351, 1994), LBS1560 (DSM19630) (WO 2009/064200), and LZ1561 (DSM23693). Isolates and mutants of Clostridium ljungdahlii include ATCC 49587 (Tanner, Int J Syst Bacteriol, 43: 232-236, 1993), PETCT (DSM13528, ATCC 55383), ERI-2 (ATCC 55380) (U.S. Pat. No. 5,593,886), C-01 (ATCC 55988) (U.S. Pat. No. 6,368,819), 0-52 (ATCC 55989) (U.S. Pat. No. 6,368,819), and OTA-1 (Tirado-Acevedo, Production of bioethanol from synthesis gas using Clostridium ljungdahlii, PhD thesis, North Carolina State University, 2010). Isolates and mutants of Clostridium ragsdalei include PI 1 (ATCC BAA-622, ATCC PTA-7826) (WO 2008/028055).
The term “derived from” refers to a microorganism is modified or adapted from a different (e.g., a parental or wild-type) microorganism, so as to produce a new microorganism. Such modifications or adaptations typically include insertion, deletion, mutation, or substitution of nucleic acids or genes.
“Substrate” refers to a carbon and/or energy source for the microorganism. Typically, the substrate is gaseous and comprises a C1-carbon source, for example, CO or CO2. Preferably, the substrate comprises a C1-carbon source of CO or CO+CO2. The substrate may further comprise other non-carbon components, such as H2, N2, or electrons.
The substrate generally comprises at least some amount of CO, such as about 1, 2, 5, 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 mol % CO. The substrate may comprise a range of CO, such as about 20-80, 30-70, or 40-60 mol % CO. Preferably, the substrate comprises about 40-70 mol % CO (e.g., steel mill or blast furnace gas), about 20-30 mol % CO (e.g., basic oxygen furnace gas), or about 15-45 mol % CO (e.g., syngas). In some embodiments, the substrate may comprise a relatively low amount of CO, such as about 1-10 or 1-20 mol % CO. The microorganism typically converts at least a portion of the CO and/or in the substrate to a product. In some embodiments, the substrate comprises no or substantially no CO.
The substrate may comprise some amount of H2. For example, the substrate may comprise about 1, 2, 5, 10, 15, 20, or 30 mol % H2. In some embodiments, the substrate may comprise a relatively high amount of H2, such as about 60, 70, 80, or 90 mol % H2. In further embodiments, the substrate comprises no or substantially no H2.
The substrate may comprise some amount of CO2. For example, the substrate may comprise about 1-80 or 1-30 mol % CO2. In some embodiments, the substrate may comprise less than about 20, 15, 10, or 5 mol % CO2. In another embodiment, the substrate comprises no or substantially no CO2.
In some embodiments, the substrate does not comprise methane or methanol.
Although the substrate is typically gaseous, the substrate may also be provided in alternative forms. For example, the substrate may be dissolved in a liquid saturated with a CO-containing gas using a microbubble dispersion generator. By way of further example, the substrate may be adsorbed onto a solid support.
The substrate and/or C1-carbon source may be or may be derived from a waste or off gas obtained as a byproduct of an industrial process or from some other source, such as from automobile exhaust fumes or biomass gasification. In certain embodiments, the industrial process is selected from the group consisting of ferrous metal products manufacturing, such as a steel mill manufacturing, non-ferrous products manufacturing, petroleum refining processes, coal gasification, electric power production, carbon black production, ammonia production, methanol production, and coke manufacturing. In these embodiments, the substrate and/or C1-carbon source may be captured from the industrial process before it is emitted into the atmosphere, using any convenient method.
The substrate and/or C1-carbon source may be or may be derived from syngas, such as syngas obtained by gasification of coal or refinery residues, gasification of biomass or lignocellulosic material, or reforming of natural gas. In another embodiment, the syngas may be obtained from the gasification of municipal solid waste or industrial solid waste.
In connection with substrates and/or C1-carbon sources, the term “derived from” refers to a substrate and/or C1-carbon source that is somehow modified or blended. For example, the substrate and/or C1-carbon source may be treated to add or remove certain components or may be blended with streams of other substrates and/or C1-carbon sources.
The composition of the substrate may have a significant impact on the efficiency and/or cost of the reaction. For example, the presence of oxygen (O2) may reduce the efficiency of an anaerobic fermentation process. Depending on the composition of the substrate, it may be desirable to treat, scrub, or filter the substrate to remove any undesired impurities, such as toxins, undesired components, or dust particles, and/or increase the concentration of desirable components.
Typically, the culture is performed in a bioreactor. The term “bioreactor” includes a culture/fermentation device consisting of one or more vessels, towers, or piping arrangements, such as a continuous stirred tank reactor (CSTR), immobilized cell reactor (ICR), trickle bed reactor (TBR), bubble column, gas lift fermenter, static mixer, or other vessel or other device suitable for gas-liquid contact. In some embodiments, the bioreactor may comprise a first growth reactor and a second culture/fermentation reactor. The substrate may be provided to one or both of these reactors. As used herein, the terms “culture” and “fermentation” are used interchangeably. These terms encompass both the growth phase and product biosynthesis phase of the culture/fermentation process.
The culture is generally maintained in an aqueous culture medium that contains nutrients, vitamins, and/or minerals sufficient to permit growth of the microorganism. Preferably the aqueous culture medium is an anaerobic microbial growth medium, such as a minimal anaerobic microbial growth medium. Suitable media are well known in the art.
The culture/fermentation should desirably be carried out under appropriate conditions for production of the target product. Reaction conditions to consider include pressure (or partial pressure), temperature, gas flow rate, liquid flow rate, media pH, media redox potential, agitation rate (if using a continuous stirred tank reactor), inoculum level, maximum gas substrate concentrations to ensure that gas in the liquid phase does not become limiting, and maximum product concentrations to avoid product inhibition. In particular, the rate of introduction of the substrate may be controlled to ensure that the concentration of gas in the liquid phase does not become limiting, since products may be consumed by the culture under gas-limited conditions.
Herein, microbial biomass itself is considered a target product. However, the microorganism also produce one or more other products of value. For instance, Clostridium autoethanogenum produces or can be engineered to produce ethanol (WO 2007/117157), acetate (WO 2007/117157), butanol (WO 2008/115080 and WO 2012/053905), butyrate (WO 2008/115080), 2,3-butanediol (WO 2009/151342), lactate (WO 2011/112103), butene (WO 2012/024522), butadiene (WO 2012/024522), methyl ethyl ketone (2-butanone) (WO 2012/024522 and WO 2013/185123), ethylene (WO 2012/026833), acetone (WO 2012/115527), isopropanol (WO 2012/115527), lipids (WO 2013/036147), 3-hydroxypropionate (3-HP) (WO 2013/180581), isoprene (WO 2013/180584), fatty acids (WO 2013/191567), 2-butanol (WO 2013/185123), 1,2-propanediol (WO 2014/0369152), and 1-propanol (WO 2014/0369152).
Operating a bioreactor at elevated pressures allows for an increased rate of gas mass transfer from the gas phase to the liquid phase. Accordingly, it is generally preferable to perform the culture/fermentation at pressures higher than atmospheric pressure. Also, since a given gas conversion rate is, in part, a function of the substrate retention time and retention time dictates the required volume of a bioreactor, the use of pressurized systems can greatly reduce the volume of the bioreactor required and, consequently, the capital cost of the culture/fermentation equipment. This, in turn, means that the retention time, defined as the liquid volume in the bioreactor divided by the input gas flow rate, can be reduced when bioreactors are maintained at elevated pressure rather than atmospheric pressure. The optimum reaction conditions will depend partly on the particular microorganism used. Also, since a given gas conversion rate is in part a function of substrate retention time and achieving a desired retention time in turn dictates the required volume of a bioreactor, the use of pressurized systems can greatly reduce the volume of the bioreactor required, and consequently the capital cost of the fermentation equipment.
The culturing of the microorganism may be performed under fermentation conditions that maximize production of microbial biomass. The method may also comprise culturing the microorganism under fermentation conditions that maximize production of or selectivity to microbial biomass. Maximizing selectivity to biomass requires operation at maximal specific growth rates or maximal microorganism dilution rate. However, operation at high microorganism dilution rates also reduces the cell concentration in the culture which hampers separations. Also, cell concentration is a key requirement for high reactor productivity. Specific growth rates or microorganism dilution rates of >1/day should be targeted, with rates of 2/day being closer to the optimum.
In a two-reactor system, biomass production rates are maximized by having high biomass production rates in both the first and second reactor. This can be achieved by either having (1) low cell viability or (2) fast specific growth rates in the second reactor. Low cell viability may be achieved from the toxicity of high product titers and may not be desirable. Fast specific growth rates may be achieved by operating with even higher values of microorganism dilution rate in the second reactor compared to the first reactor.
This relationship is captured by the following equation: μ2=Dw2−Dw1*(X1/X2)*(V1/V2), where μ2 is the specific growth rate in the second reactor in a two reactor system which will need to be maximized to increase selectivity to biomass, Dw2 and Dw1 are the microorganism dilution rates in the second and first reactors in a two reactor system, respectively, X2 and X1 are the biomass titers in the second and first reactors in a two reactor system, respectively, and V2 and V1 are the reactor volumes in the second and first reactors in a two reactor system, respectively.
According to this equation, to maximize the selectivity to biomass in a second reactor, the microorganism dilution rate in the second reactor, Dw2, will need to be increased to achieve a specific growth rate, μ2, in the second reactor of >0.5/day, ideally targeting 1-2/day.
Products may be separated or purified from a fermentation broth using any method or combination of methods known in the art, including, for example, fractional distillation, evaporation, pervaporation, gas stripping, phase separation, and extractive fermentation, including for example, liquid-liquid extraction. In certain embodiments, products are recovered from the fermentation broth by continuously removing a portion of the broth from the bioreactor, separating microbial cells from the broth (conveniently by filtration), and recovering one or more target products from the broth. Alcohols and/or acetone may be recovered, for example, by distillation. Acids may be recovered, for example, by adsorption on activated charcoal. Cell-free permeate remaining after products have been removed is also preferably returned to the bioreactor. Additional nutrients (such as B vitamins) may be added to the cell-free permeate to replenish the medium before it is returned to the bioreactor.
The following examples further illustrate the disclosure but, of course, should not be construed to limit its scope in any way.
This example describes the composition of C. autoethanogenum DSM23693 microbial biomass.
1AOAC 944.13, AOAC 960.46, AOAC 945.74, AOAC 961.15, AOAC 940.33, AOAC 942.23, AOAC 953.17, AOAC 957.17
2Methods used: AOAC 944.13, AOAC 960.46, AOAC 945.74, AOAC 961.15, AOAC 940.33, AOAC 942.23, AOAC 953.17, AOAC 957.17, AOAC 988.15, R. Schuster, “Determination of Amino Acids in Biological, Pharmaceutical, Plant and Food Samples by Automated Precolumn Derivatization and HPLC”, Journal of Chromatography, 1988, 431, 271-284. Henderson, J. W., Brooks, A., “Improved Amino Acid Methods using Agilent Zorbax Eclipse Plus C18 Columns for a Variety of Agilent LC Instrumentation and Separation Goals,” Agilent Application Note 5990-4547 (2010)., Henderson, J. W., Ricker, R. D. Bidlingmeyer, B. A., Woodward, C., “Rapid, Accurate, Sensitive, and Reproducible HPLC Analysis of Amino Acids, Amino Acid Analysis Using Zorbax Eclipse-AAA columns and the Agilent 1100 HPLC,” Agilent Publication, 2000.
This example describes general methods for culturing C. autoethanogenum and C. ljungdahlii. Such methods are also well known in the art.
C. autoethanogenum DSM10061 and DSM23693 (a derivate of DSM10061) and C. ljungdahlii DSM13528 were sourced from DSMZ (The German Collection of Microorganisms and Cell Cultures, Inhoffenstraße 7 B, 38124 Braunschweig, Germany).
Strains were grown at 37° C. in PETC medium at pH 5.6 using standard anaerobic techniques (Hungate, Methods Microbiol, 3B: 117-132, 1969; Wolfe, Adv Microbiol Physiol, 6: 107-146, 1971). Fructose (heterotrophic growth) or 30 psi CO-containing steel mill gas (collected from New Zealand Steel site in Glenbrook, NZ; composition: 44% CO, 32% N2, 22% CO2, 2% H2) in the headspace (autotrophic growth) was used as substrate. For solid media, 1.2% bacto agar (BD, Franklin Lakes, N.J. 07417, USA) was added.
All references, including publications, patent applications, and patents, cited herein are hereby incorporated by reference to the same extent as if each reference were individually and specifically indicated to be incorporated by reference and were set forth in its entirety herein. The reference to any prior art in this specification is not, and should not be taken as, an acknowledgement that that prior art forms part of the common general knowledge in the field of endeavour in any country.
The use of the terms “a” and “an” and “the” and similar referents in the context of describing the disclosure (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. The terms “comprising,” “having,” “including,” and “containing” are to be construed as open-ended terms (i.e., meaning “including, but not limited to”) unless otherwise noted. Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein, is intended merely to better illuminate the disclosure and does not pose a limitation on the scope of the disclosure unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the disclosure.
Preferred embodiments of this disclosure are described herein. Variations of those preferred embodiments may become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventors expect skilled artisans to employ such variations as appropriate, and the inventors intend for the disclosure to be practiced otherwise than as specifically described herein. Accordingly, this disclosure includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the disclosure unless otherwise indicated herein or otherwise clearly contradicted by context.
This application is a continuation of International Application No. PCT/US2020/022659, filed on Mar. 13, 2020, which claims the benefit of U.S. Provisional Patent Application No. 62/818,579, filed on Mar. 14, 2019, the entirety of which is incorporated herein by reference.
| Number | Date | Country | |
|---|---|---|---|
| 62818579 | Mar 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | PCT/US2020/022659 | Mar 2020 | US |
| Child | 17447266 | US |
